Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  05/28/2009
 
Trade Name:  Besivance
 
Generic Name or Proper Name (*):  besifloxacin ophthalmic suspension
 
Indications Studied:  Treatment of bacterial conjunctivitis
 
Label Changes Summary:  * Efficacy in pediatric patients 1 year and older has been demonstrated in controlled clinical trials * Safety and effectiveness in infants < 1 year of age have not been established * There is no evidence that the ophthalmic administration of quinolones has any effect on weight bearing joints * Information on AE profile and clinical study * New drug
 
Product Labeling:  Labeling  Opens a new window
 
PREA(P):  P
 
Sponsor:  Bausch and Lomb
 
NNPS:  FALSE
 
Therapeutic Category:  Antibiotic, topical
 
-
-